findmyKOL
Clinical trialNCT04852887RecruitingPhase 3Interventional

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

SponsorNRG OncologyEnrollment1,670Stage I Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

832 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Atlantic Health Sciences Corporation-Saint John Regional Hospital

    Saint John, New Brunswick, Canada

    Farah Naz
    Recruiting
  • Kingston Health Sciences Centre

    Kingston, Ontario, Canada

    Timothy Owen
    Recruiting
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

    Eileen Rakovitch
    Recruiting
  • Chum - Centre Hospitalier de L'Universite de Montreal

    Montreal, Quebec, Canada

    Jean-Marc Bourque
    Recruiting
  • Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)

    Québec, Quebec, Canada

    Valerie Theberge
    Recruiting
  • Allan Blair Cancer Centre

    Regina, Saskatchewan, Canada

    Derek Suderman
    Recruiting
  • Saskatoon Cancer Centre

    Saskatoon, Saskatchewan, Canada

    Ali A. El-Gayed
    Recruiting
Hong Kong
  • Pamela Youde Nethersole Eastern Hospital

    Chai Wan, Hong Kong

    Suspended
Japan
  • Ehime University Hospital

    Tōon, Ehime, Japan

    Yoshiaki Kamei
    Recruiting
  • Hokkaido University Hospital

    Sapporo, Hokkaido, Japan

    Masato Takahashi
    Recruiting
  • Hyogo Cancer Center

    Akashi, Hyōgo, Japan

    Koji Matsumoto
    Recruiting
  • Gunma University Hospital

    Gunma, Maebashi, Japan

    Sasagu Kurozumi
    Recruiting
  • the Cancer Institute Hospital of Jfcr

    Koto-ku, Tokyo, Japan

    Takehiko Sakai
    Recruiting
  • Hiroshima University Hospital

    Hiroshima, Japan

    Hideo Shigematsu
    Recruiting
  • Kyoto University Hospital

    Kyoto, Japan

    Norikazu Masuda
    Recruiting
  • Shikoku Cancer Center

    Matsuyama, Japan

    Daisuke Takabatake
    Recruiting
  • Nagoya University Hospital

    Nagoya, Japan

    Yuko Takano
    Recruiting
  • Kindai University

    Osaka, Japan

    Yoshifumi Komoike
    Recruiting
  • Saitama Medical University International Medical Center

    Saitama, Japan

    Akihiro Fujimoto
    Recruiting
  • National Cancer Center Hospital

    Tokyo, Japan

    Shin Takayama
    Recruiting
United States
  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama, United States

    Active, not recruiting
  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama, United States

    Ayesha Munir
    Recruiting
  • Kingman Regional Medical Center

    Kingman, Arizona, United States

    John A. Ellerton
    Recruiting
  • Cancer Center at Saint Joseph'S

    Phoenix, Arizona, United States

    Shahzad Siddique
    Recruiting
  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona, United States

    Active, not recruiting
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

    Sanjay Maraboyina
    Recruiting
  • Kaiser Permanente-Anaheim

    Anaheim, California, United States

    Aakash Batra
    Recruiting
  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California, United States

    Samantha A. Seaward
    Recruiting
  • Mission Hope Medical Oncology - Arroyo Grande

    Arroyo Grande, California, United States

    Shahzad Siddique
    Recruiting
  • Pcr Oncology

    Arroyo Grande, California, United States

    John A. Ellerton
    Recruiting
  • Sutter Auburn Faith Hospital

    Auburn, California, United States

    Kristie A. Bobolis
    Recruiting
  • Sutter Cancer Centers Radiation Oncology Services-Auburn

    Auburn, California, United States

    Kristie A. Bobolis
    Recruiting
  • Kaiser Permanente-Bellflower

    Bellflower, California, United States

    Aakash Batra
    Recruiting
  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California, United States

    Kristie A. Bobolis
    Recruiting
  • Tower Cancer Research Foundation

    Beverly Hills, California, United States

    Suspended
  • Mercy Cancer Center - Carmichael

    Carmichael, California, United States

    Shahzad Siddique
    Recruiting
  • Mercy San Juan Medical Center

    Carmichael, California, United States

    Matthew D. Wheatley
    Recruiting
  • Epic Care-Dublin

    Dublin, California, United States

    Active, not recruiting
  • Kaiser Permanente Dublin

    Dublin, California, United States

    Samantha A. Seaward
    Recruiting
  • Mercy Cancer Center - Elk Grove

    Elk Grove, California, United States

    Shahzad Siddique
    Recruiting
792 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Endocrine Therapy
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Jun 2021
Primary completion
8 Apr 2031
Completion
31 Jul 2041
Last update posted
23 Apr 2026
Registered enrollment
1,670
Registry id
NCT04852887

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.